Search

Your search keyword '"Harvey, Ruth"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Harvey, Ruth" Remove constraint Author: "Harvey, Ruth" Database Academic Search Index Remove constraint Database: Academic Search Index
62 results on '"Harvey, Ruth"'

Search Results

1. A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene.

2. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.

3. The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein.

4. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions.

5. A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine.

6. An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs

7. Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards

8. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules

9. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)

10. Restrictions to the Adaptation of Influenza A Virus H5 Hemagglutinin to the Human Host.

12. THE EMPRESS EUDOXIA AND THE TROUBADOURS.

13. Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.

14. Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

15. `Joglars' and the professional status of the early troubadours.

17. A Nourishing Spirituality.

18. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.

19. The Judgement of Urines.

20. A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes.

21. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.

22. Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.

23. COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

24. Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

25. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.

26. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.

27. Improved Antigen Yield in Pandemic H1N1 (2009) Candidate Vaccine Viruses with Chimeric Hemagglutinin Molecules.

28. Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.

29. Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.

31. Electron cryotomography of SARS-CoV-2 virions reveals cylinder-shaped particles with a double layer RNP assembly.

32. SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.

33. Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

34. Permissible Variation in the 3' Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14.

35. The development of vaccine viruses against pandemic A(H1N1) influenza

36. Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease.

37. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.

38. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.

39. SARS-CoV-2 mucosal neutralising immunity after vaccination.

40. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

41. Compilatio (Book).

43. Troubadour Lyrics (Book Review).

45. Three-dose vaccination elicits neutralising antibodies against omicron.

46. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

47. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

48. Reviews.

50. Le 'Breviari d'Amor'

Catalog

Books, media, physical & digital resources